Docstoc

Preclinical Models

Document Sample
Preclinical Models Powered By Docstoc
					Preclinical Models - Preclinical CROs will Continue to Improve the Quality and
Accuracy of Data for Targeted Therapies

New Approaches for Conducting Preclinical Studies Improve the Quality of Preclinical
Data and Speed up the Preclinical R&D Process

Pharmaceutical/biotechnology companies partner with CROs, academic and government
institutions to design and develop new approaches and models for conducting preclinical
research. Advancements in molecular biology/genetic engineering and computational
methods help researchers to tackle various problems in the preclinical research.

Simulation and system biology models improve the quality and reliability of preclinical
data. Novel models by several pharmaceutical companies and contract research
organizations proved to be effective in reducing preclinical process cycle time.

For Sample Pages, please click or add the below link to your browser:
http://www.gbiresearch.com/RequestSamplePages.aspx?ID=Preclinical-Models-
Preclinical-CROs-will-Continue-to-Improve-the-Quality-and-Acccuracy-of-Data-for-
Targeted-
Therapies&Title=Pharmaceuticals_and_Healthcare&ReportType=Industry_Report

Preclinical studies make use of systems or models such as in-vitro, in-vivo and in-silico
models, for conducting a wide range of preclinical research and development studies.
Absorption, distribution, metabolism, excretion and toxicology (ADMET) studies are
conducted initially to investigate and correlate the test compound’s absorption,
distribution, metabolism, excretion, and toxicology profile in preclinical systems with
humans. There is considerable number of contract research organizations (CROs),
providing a wide range of preclinical design and testing services. Some of the top CROs
such as Charles River Laboratories, Covance and Cyprotex offer both customized and
standardized preclinical services and models to their clients (pharmaceutical and
biotechnology companies) and they continue to grow with strategic acquisitions and
partnerships. Furthermore CROs from Asian countries (especially from India and China)
such as Jubilant Biosys, Advinus and Shanghai ChemPartner also emerging up with their
customized preclinical offerings.

GBI Research, the leading business intelligence provider, has released its latest report,
“Preclinical Models- Preclinical CROs will Continue to Improve the Quality and
Accuracy of Data for Targeted Therapies” that provides key data, information and
analysis of the major trends and developments in preclinical studies and preclinical
outsourcing business. The report provides a comprehensive insight into key technological
developments, new approaches in developing preclinical models. The report talks about
the key outsourcing business models and factors that are driving the global preclinical
outsourcing market. The report also provides a detailed analysis of global preclinical
market in terms of preclinical spending and preclinical outsourced value. The report also
provides key alliances and acquisitions related to preclinical studies among CROs.
This report is built using data and information sourced from proprietary databases,
primary and secondary research and in house analysis by GBI Research’s team of
industry experts.

For further details, please click or add the below link to your browser:
http://www.gbiresearch.com/Report.aspx?ID=Preclinical-Models-Preclinical-CROs-will-
Continue-to-Improve-the-Quality-and-Acccuracy-of-Data-for-Targeted-
Therapies&ReportType=Industry_Report&coreindustry=ALL&Title=Pharmaceuticals_a
nd_Healthcare

Visit our report store: http://www.gbiresearch.com

For more details contact:
pressreleases@gbiresearch.com
North America:        +1 646 395 5477
Europe:               +44 207 753 4299
                      +44 1204 543 533
Asia Pacific:         +91 40 6616 6782

				
DOCUMENT INFO
Shared By:
Categories:
Stats:
views:17
posted:2/25/2011
language:English
pages:2
Description: New Approaches for Conducting Preclinical Studies Improve the Quality of Preclinical Data and Speed up the Preclinical R&D Process